Michael Hallek to Graft vs Host Disease
This is a "connection" page, showing publications Michael Hallek has written about Graft vs Host Disease.
Connection Strength
0.098
-
Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience. Haematologica. 2019 09; 104(9):1798-1803.
Score: 0.035
-
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT. Bone Marrow Transplant. 2018 03; 53(3):255-263.
Score: 0.032
-
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial. Blood. 2017 09 21; 130(12):1477-1480.
Score: 0.031